throbber
University of California School of Pharmacy
`
`CURRICULUM VITAE
`
`
 
`
` 

`
`
`
`
`
`
`
`Leslie Z. Benet
`
`Professor, Above Scale
`Departments of Bioengineering & Therapeutic Sciences
` !"#$%!&'($
`and Pharmaceutical Chemistry
`
`
`Schools of Pharmacy and Medicine
`/,012,34536,7,83
`
`Visiting Professor, Peking University Third Hospital
`;<=>?@@=<A3BC=D?3EFGH?3
`Visiting Professor, First Clinical Medical College of Zhengzhou University
`I?JG<KL?MK@3=>3NO=?MPOM??<OMP3Q3RS?<GJ?TKOF3EFO?MF?@3
`Guest Professor, Sichuan University
`GMU3;SG<LGF?TKOFGH3VS?LO@K<W3
`EFS==H@3=>3;SG<LGFW3GMU3X?UOFOM?3
`Room U-68, Box 0912
`University of California San Francisco
`YO@OKOMP3;<=>?@@=<A3;?ZOMP3[MOD?<@OKW3RSO<U3\=@JOKGH3
`San Francisco, CA 94143-0912
`YO@OKOMP3;<=>?@@=<A3]O<@K3VHOMOFGH3X?UOFGH3V=HH?P?3=>3^S?MP_S=T3[MOD?<@OKW3
``T?@K3;<=>?@@=<A3EOFSTGM3[MOD?<@OKW3
`Voice: (415)476-3853
`Fax:
`(415)476-8887
`d==L3[efgA3N=h3ijkl3
`Email: leslie.benet@.ucsf.edu
`[MOD?<@OKW3=>3VGHO>=<MOG3EGM3]<GMFO@F=3
`www: http://bts.ucsf.edu/pspg/facultv/pages/benet.html
`EGM3]<GMFO@F=A3VB3jmkmneijkl3
`
`
`
`Name:
`
`
`
`Position:
`
`)*+,-..
`3
`9:0282:7-.
`3
`3
`3
`Address:
`
`3
`3
`
`3
`3
`3
`
`3 3
`
`3
`3
`
`3 a
`
`bbc,00-3
`3
`3
`3
`3
`
`3 3
`
`EDUCATION
`3
`Y=OF?o33pmkqr3msfengqn3
`(Undergraduate, Graduate, Postgraduate, Fellowships, Honorary Degrees)
`3
`3
`]Gho33 pmkqr3msfegggs3
`3
`3
`tLGOHo3H?@HO?uC?M?KvTF@>u?UT33
`1959
`A.B., English
`wwwo33SKKJoxxCK@uTF@>u?UTxJ@JPx>GFTHKWxJGP?@xC?M?KuSKLH33
`3
`3
`B.S., Pharmacy
`1960
`
`
`M.S., Pharmaceutical Chemistry
`1962
`yz{| }~
`
`z€‚ƒ„ƒ…†…‡‚ˆ
`‰ƒ…†…‡‚ˆ
`Š‹Œ‡„ƒ…†…‡‚ˆ
`‚ŽŽ‹Œ‘’Œˆ“‹€‹ƒ…ƒ”y‚„ƒ‚‚Œ•
`
`University of Michigan
`
`
`Ann Arbor, MI
`™š›šœ
ž 
`
`
` –—˜—
`
`›ššœ
`
`
`
` –—Ÿ 
`
`
` –—Ÿ¡
`
`¢ššœ
`£ 
` 
`
`1965
`PhD., Pharmaceutical Chemistry
`
`
`
`
`
`
`
 
`
`¢  ž

`
`University of California

`™¤œ
`¢¥
`
`
`
`
`San Francisco, CA
`
`
`
`
`
` –—Ÿ˜
`
`1987
`
`
`
`
`
`
`
`
`
`
`
`
`
`š¦šœ
`£ 
` 
`
`Doctor of Pharmacy, honoris causa
`Uppsala University
`
`
 
`
` 

`
`Uppsala, Sweden
`

`§
 œ
`™
`
`
`1995
`PhD., honoris causa
`–—¨©ª
`¦
`
`œ
`
 
`£
`
`Leiden University
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` ««
`
 
`
`Leiden, The Netherlands
` ««œ
`¬­

`
`
`
`
`
`
`
`
`1997
`
` –——˜
`
`
`
`
`
`
`
`0^01/18
`
`
`
`
`
` –——©
`
`
`
`
`
`D.Sc, honoris causa
`š¦šœ
`
 
`£
`
`University of Illinois at Chicago
`® ­

`
 
`
`® ­
œ
`¯
`°
­
`
`1
`
`¦ššœ
`
 
`£
`
`
`
 
`
`¥
 
`
` ž
`
`
`   
`
`
`
`
`
` 
`
`BENET
`APOTEX ET AL. - EXHIBIT 1048
`Apotex Inc. et al. v. Novartis AG
`IPR2017-00854
` 
`
`MYLAN - EXHIBIT 1046
`
`

`

`
`
`
`UCSF School of Pharmacy Curriculum Vitae
` §
`
`
`
`£ ££
`Õ 
`
`Chicago, Illinois
` žœ
`¥
 
`
`
`D.Sc, honoris causa
`¦ššœ
`
 
`£
`
`Philadelphia College of Pharmacy and Science
` ­« 
`ž
`
`
`
­
` 

`
`Philadelphia, Pennsylvania
` ­« œ
`


`
`
`
`
`
`
`
`
`
`
`
`
`1997
`
` –——©
`
`
`
`
`
`
`
`
`
`
`
`1999
`D.Sc., honoris causa
`
` –———
`
`¦ššœ
`
 
`£
`
`Long Island University
`
`
`
`®
ž
`¥
­
`
 
`
`Brooklyn, New York
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`›Ö
œ
`°¬
`×Ö
`
`
`
`Ph.D., honoris causa
`2005
`š¦šœ
`
 
`£
`
`¡  ˜
`
`
`
`University of Athens,
`
`
 
`
`™

`
`
`Athens, Greece
`™

`Ø
`
`
`2010
`
`
`Ph.D., honoris causa
`
` ¡ – 
`
`š¦šœ
`
 
`£
`
`Catholic University of Leuven,
`
`
`
` 
`
 
`
`®£
œ
`
`Leuven, Belgium
`
`
`
`®£
œ
`›ž £
`
`
`
`
`2011
`
`
`D.Sc., honoris causa
`
` ¡ ––
`
`¦ššœ
`
 
`£
`
`University of Michigan
`
`
`
`
`
 
`
`¢  ž

`
`Ann Arbor, Michigan
`
`
`

`™¤œ
`¢  ž

`
`2016
`
`
`Ph.D., honoris causa
`
` ¡ –Ÿ
`
`š¦šœ
`
 
`£
`
`Universidade de Lisboa
`
`
`
`
`
 ­­
`­
`® ¤
`
`Lisbon, Portugal
`
`
`
`® ¤
œ
`£ž
`
`Specialty; Subspecialty
`
`
`ْ‚Ú‘…Ž‡”Û
`ن܌’‚Ú‘…Ž‡”
`
`
`
`Pharmacokinetics/Pharmacodynamics
`Ö
 Ý­
 
`
`
`
`
`Biopharmaceutics and Drug Delivery
`› «£ 
`
­
`¦£ž
`¦ 
`
`
`
`
`Drug Metabolism and Drug Transporters
`¦£ž
`¢¤ 
`
­
`¦£ž
`¯
«
`
`
`
`
`Measures of Hepatotoxicity
`
`
`
`¢£
`
`Þ«ß  
`
`Professional Licensures
`
`
`Šƒ‹à‚ŒŒ‘‹€…Ž
`á‘Ú‚€Œ†ƒ‚Œ
`
`
`
`Licentiate in Pharmacy, Ohio
`1960
`® 
 
`

`œ
`â 
`
`
` –—Ÿ 
`
`Credentialed Applied Pharmacologist, American Board of Clinical Pharmacology
`1991
`­
 ­
`™«« ­
`ž œ
`™ 

`›­
`
`

`ž
`
`
` –——–
`
`
`
`Academic and Professional Positions Held
`
`
`|څ‚ã‘Ú
`…€
`Šƒ‹à‚ŒŒ‘‹€…Ž
`Š‹Œ‘‡‘‹€Œ
`“‚Ž
`
`
`
`Assistant Professor
`1965-69
`™ 

`
`
`
` –—Ÿ˜äŸ—
`
`
`
`College of Pharmacy
`ž
`
`
`
`
`
`
`Washington State University
`å
ž

`
`
 
`
`
`
`
`Pullman, WA
`£
œ
`å™
`
`
`
`
`
`
`Assistant Professor
`1969-71
`™ 

`
`
`
` –—Ÿ—ä©–
`
`Associate Professor
`1971-76
`™ 
`
`
`
` –—©–ä©Ÿ
`
`Professor
`1976-95
`
`
`
`
` –—©Ÿä—˜
`
`
`
`Departments of Pharmacy and Pharmaceutical Chemistry
`¦«

`
`
`
­
`£ 
` 
`
`
`
`
`School of Pharmacy
`yi/2018
`2
`
`
`
`
`
`
`
` 
`   
`
`
`
`BENET
` 
`
`

`

`
`
`
`UCSF School of Pharmacy Curriculum Vitae
` §
`
`
`
`£ ££
`Õ 
`
`University of California
`
`
`
`
`
 
`
` 

`
`San Francisco, CA
`
`
`
`

`§
 œ
`™
`
`
`
`1996-2009
`Departments of Biopharmaceutical Sciences and Pharmaceutical Chemistry
`
` –——Ÿä¡  —
` ¦«

`
`› «£ 
` 

`
­
`£ 
` 
`
`School of Pharmacy
`
`
`
`
`
`
`
`University of California
`
`
 
`
` 

`
`
`
`
`San Francisco, CA
`
`
`
`

`§
 œ
`™
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2009 -*
`Departments of Bioengineering & Therapeutic Sciences and
`
` ¡  —
`äç
`
`
`
`
`
`
`
`
`
`
`
`
`
`¦«

`
`› 
ž

ž

`¯«£ 
` 

`
­
`
`Pharmaceutical Chemistry
`£ 
` 
`
`
`
`
`Schools of Pharmacy and Medicine
`
`
`
`
­
`¢­ 

`
`
`
`
`University of California
`
`
 
`
` 

`
`
`
`
`San Francisco, CA
`

`§
 œ
`™
`
`
`
`
`
`
`Visiting Professor
`2010-*
`Õ  
ž
`
`
`
` ¡ – äç
`
`Peking University Third Hospital
`
`Ö
ž
`
 
`¯ ­
`Þ« 
`
`
`
`
`Beijing, China
`› é
žœ
`

`
`
`
`
`
`
`Visiting Professor
`2012-*
`Õ  
ž
`
`
`
` ¡ –¡äç
`
`First Clinical Medical College of Zhengzhou University, and
`§ 
`

`¢­ 
`ž
`
`ê
žë£
`
 œ
`
­
`
`
`
`
`
`Institute of Clinical Medicine
 £
`
`

`¢­ 

`
`
`
`
`Zhengzhou University
`ê
žë£
`
 
`
`
`
`
`Henan Province, China
`Þ


`
œ
`

`
`
`
`
`
`
`Guest Professor
`2014-*
`Ø£
`
`
`
`
` ¡ –ìäç
`
`Sichuan University
` £

`
 
`
`
`
`
`Chengdu, China
`
ž­£œ
`

`
`
`
`
`
`BENET
` 
`
`
`  |
`
`Administrative Positions Held
`ã‘€‘Œ‡ƒ…‡‘í‚
`Š‹Œ‘‡‘‹€Œ
`“‚Ž
`
`
`
`Co-Director, Clinical Pharmacology-
`1971-73
`ä¦ œ
`

`žä
`
`
` –—©–ä©î
`
`Pharmacokinetics Training Grant
`
`Ö
 
`¯
ž
`Ø

`
`
`
`
`
`
`Vice Chairman
`1973-78
`Õ 
` 

`
`
` –—©î䩨
`
`1975
`Acting Chairman (Mar-Jun; Sept-Dec)
`™
ž
` 

`ï¢äð£
ñ
`«ä¦ò
`
`
` –—©˜
`
`Chairman
`1978-95
` 

`
`
` –—©¨ä—˜
`
`
`
`Department of Pharmacy
`¦«

`
`
`
`
`
`
`School of Pharmacy
`
`
`
`
`
`
`
`University of California
`
`
 
`
` 

`
`
`
`
`San Francisco, CA
`
`
`
`

`§
 œ
`™
`
`
`
`1996-1998
`Chairman
`
` –——Ÿä–——¨
`  

`
`
`
`Department of Biopharmaceutical Sciences
`¦«

`
`› «£ 
` 

`
`
`
`
`
`School of Pharmacy
`
`
`
`
`
`
`
`University of California
`
`
 
`
` 

`
`
`
`
`San Francisco, CA
`
`
`
`

`§
 œ
`™
`
`
`
`1977-*
`Co-Director, Drug Studies Unit
`
` –—©©äç
`
`ä¦ œ
`¦£ž
`£­ 
`

`
`1979-1998
`Director, Drug Kinetics and Dynamics Center
`
` –—©—ä–——¨
` ¦ œ
`¦£ž
 
`
­
`¦
 
`

`
`(Funded by National Institute of General Medical Sciences)
`
`
`
`
`泥
­­
`¤
`° 

 £
`
`Ø

`¢­ 
` 
ò
`
`
`
`1987-95
`Principal Investigator (San Francisco Campus),
`
` –—¨©ä—˜
`
`
 «
 ž
`ï

`§
 
`«£òœ
`
`
`Program Project Grant: Health Effects of Toxic Substances
`yi/2018
`3
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ž
`é
`Ø

`
`Þ
`
`
`¯ß 
`£¤

`
`   
`æ
`
`
`
`

`

`
`
`
`UCSF School of Pharmacy Curriculum Vitae
` §
`
`
`
`£ ££
`Õ 
`
`(Funded by National Institutes of Environmental Health Sciences)
`泥
­­
`¤
`° 

 £
`
 


`Þ
` 
ò
`
`University of California
`
`
 
`
` 

`
`San Francisco, CA
`

`§
 œ
`™
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`öööööööööööö
`To present
`
`
`ç¯
`«

`
`
`   
`
`Elected Positions in Professional Societies
`Ž‚Ú‡‚
`Š‹Œ‘‡‘‹€Œ
`‘€
`Šƒ‹à‚ŒŒ‘‹€…Ž
`ًڑ‚‡‘‚Œ
`
`
`
`1974-75
`Secretary
`
` –—©ì䩘
`
`
`
`1975-76
`Vice-Chairman
`
` –—©˜ä©Ÿ
`
`Õ ä 

`
`1976-77
`Chairman
`
` –—©Ÿä©©
`
` 

`
`
`
`Basic Pharmaceutics Section
`› 
`£ 
` 

`
`
`
`
`Academy of Pharmaceutical Research and Science (formerly Academy of
`™­
`
`£ 
`÷
`
­
` 

`ï
`™­
`
`
`
`
`
`Pharmaceutical Sciences)
`£ 
` 
ò
`
`
`
`
`
`
`
`
`
`
`
`
`
`1978-81
`
` –—©¨ä¨–
`
`and 1991-95
`
` 
­
`–——–ä—˜
`
`1995-96
`
` –——˜ä—Ÿ
`
`1996-97
`
` –——Ÿä—©
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1979-82
`
` –—©—䨡
`
`1984-85
`
` –—¨ì䨘
`
`1985-86
`
` –—¨˜ä¨Ÿ
`
`1986-87
`
` –—¨Ÿä¨©
`
`
`
`
`
`
`
`
`
`
`
`1986
`
` –—¨Ÿ
`
`1987
`
` –—¨©
`
`1988-93
`
` –—¨¨ä—î
`
`1991-92
`
` –——–ä—¡
`
`
`
`
`
`
`
`
`
`
`1987-2016
`Member, Board of Directors
`
` –—¨©ä¡ –Ÿ
` ¢¤œ
`›­
`
`¦ 
`
`Member, Executive Committee
`1993-95
`¢¤œ
`ß£ 
` 
`
`
` –——î䗘
`
`and 2002-2015
`
` 
­
`¡  ¡ä¡ –˜
`
`
`American Foundation for Pharmaceutical Education
`™ 

`§£
­ 

`
`£ 
`­£ 

`
`
`
`
`
`
`
`
`yi/2018
`   
`
`
`
`Member-at-Large, Executive Committee
`¢¤ä䮞œ
`ß£ 
` 
`
`Chair-Elect
` ä
`
`Chair
` 
`
`Pharmaceutical Sciences Section
`£ 
` 

` 

`
`American Association for the Advancement of Science
`™ 

`™  

`
`
`™­


`
` 

`
`
`Member-at-Large, Executive Committee
`¢¤ä䮞œ
`ß£ 
` 
`
`President-Elect
`
` ­
ä
`
`President
`
` ­

`
`Past-President
`ä ­

`
`Academy of Pharmaceutical Research and Science (formerly Academy of
`™­
`
`£ 
`÷
`
­
` 

`ï
`™­
`
`
`Pharmaceutical Sciences)
`£ 
` 
ò
`
`President
`
` ­

`
`Treasurer
`¯£
`
`Member, Board of Directors
`¢¤œ
`›­
`
`¦ 
`
`Chair, Board of Directors
` œ
`›­
`
`¦ 
`
`American Association of Pharmaceutical Scientists
`™ 

`™  

`
`£ 
` 
 
`
`
`4
`õ
`
`BENET
` 
`
`

`

`
`
`
`Member, Bioavailability, Bioequivalence and Dissolution Subcommittee
`¢¤œ
`›  ¤  œ
`› ù£ 

`
­
`¦ £ 

`£¤ 
`
`Committee of Revision
` 
`
`÷  

`
`Delegate, UCSF School of Pharmacy,
`¦žœ
` §
`
`
`œ
`
`
`
`
`
`
`The United States Pharmacopeial Convention
`¯
`
­
`
`« 
`

 

`
`
`UCSF School of Pharmacy Curriculum Vitae
` §
`
`
`
`£ ££
`Õ 
`
`Specialist Member, Board of Pharmaceutical Sciences
`1988-96
`«  
`¢¤œ
`›­
`
`£ 
` 

`
`
` –—¨¨ä—Ÿ
`
`Chairman, Board of Pharmaceutical Sciences
`1996-2000
`–——Ÿä¡   
`  
œ
`›­
`
`£ 
` 

`
`
`
`Past Chair, Member Executive Committee, Board of Pharmaceutical Sciences
`2000-2004
`¡   ä¡  ì
` 
` œ
`¢¤
`ß£ 
` œ
`›­
`
`£ 
` 

`
`Chair, FIP Foundation for Education and Research
`2007-2012
`¡  ©ä¡ –¡
`
`
`
`
`
`
`
`
`
`
`
`
` œ
`§¥
`§£
­ 

`
`­£ 

`
­
`÷
`
`
`
`FIP (International Pharmaceutical Federation)
`§¥
`ï¥

 

`£ 
`§­ 
ò
`
`
`
`
`
`
`
`
`
`
`
`1990-95
`
` –—— ä—˜
`
`
`
`
`2005-*
`
` ¡  ˜äç
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1991-95
`Councilor
`
` –——–ä—˜
`
`£
 
`
`1998-2000
`Treasurer
`
` –——¨ä¡   
` ¯£
`
`
`
`International Society for the Study of Xenobiotics

 

` 
`
`
`£­
`
`ú
¤  
`
`
`
`
`
`
`
`
`
`1992-93
`
` –——¡ä—î
`
`1993-94
`
` –——îä—ì
`
`1994-95
`
` –——ì䗘
`
`
`
`
`
`
`
`
`
`
`1993-97
`
` –——î䗩
`
`1996-97
`
` –——Ÿä—©
`
`
`
`
`
`
`
`
`
`President-Elect and Member of the Board of Directors
`
` ­
ä
`
­
`¢¤
`
`
`›­
`
`¦ 
`
`President and Chair of the Board of Directors
`
` ­

`
­
` 
`
`
`›­
`
`¦ 
`
`Past-President and Member of the Board of Directors
`ä ­

`
­
`¢¤
`
`
`›­
`
`¦ 
`
`American Association of Colleges of Pharmacy
`™ 

`™  

`
`ž
`
`
`
`
`Member, Membership Committee
`¢¤œ
`¢¤ «
` 
`
`Chair - Section 10
` 

` 

`– 
`
`Institute of Medicine, (now National Academy of Medicine) National Academy of Sciences
 £
`
`¢­ 


`° 

`™­
`
`¢­ 

`° 

`™­
`
` 

`
`
`
`
`  |
`
`
`
`
`
`
`
`Appointments to Editorial Boards of Scholarly Journals
`’’‹‘€‡ã‚€‡Œ
`‡‹
`‘‡‹ƒ‘…Ž
`‹…ƒŒ
`‹à
`Ùڐ‹Ž…ƒŽ”
`ü‹†ƒ€…ŽŒ
`
`
`
`Associate Editor, Journal of Pharmacokinetics and Biophartmceutics
`1972-1975
`
` –—©¡ä–—©˜
` ™ 
`­ œ
`ýþ  þ
 

` 
þ
` 

`
`
`
`
`Editor, Journal of Pharmacokinetics and B iopharmaceu tics
`1976-1997
`
` –—©Ÿä–——©
` ­ œ
`ýþ  þ
 

` 
þ
` 

`
`
`
`
`Member, Editorial Board, Pharmacology
`1978-*
`¢¤œ
`­  
`›­œ
`
`þþ
`
` –—©¨äç
`
`Member, Editorial Board, Pharmacy International
`1979-1982
`–—©—ä–—¨¡
` ¢¤œ
`­  
`›­œ
`
`  
þ 
`Member, Editorial Board, Pharmaceutical Research
`1983-1995
`–—¨î䖗—˜
` ¢¤œ
`­  
`›­œ
`
` 

`  
`
`
`
`
`Member, Editorial Advisory Board, ISI Atlas of Science: Pharmacology
`1987-1989
`
` –—¨©ä–—¨—
` ¢¤œ
`­  
`™­ 
`›­œ
` !"#$!#%&'()!*+
`Member, Editorial Board, Pharmaceutical News
`1994-1999
`–——ì䖗——
` ¢¤œ
`­  
`›­œ
`
` 

` , -
`Associate Editor, Pharmacology and Therapeutics
`1995-2000
`–——˜ä¡   
` ™ 
`­ œ
`
`þþ .  

`
`Member, Editorial Board, Clinical Trials Advisor
`1996-1998
`–——Ÿä–——¨
` ¢¤œ
`­  
`›­œ
`/


` .
01
þ 
`5
`
`2/1/2018
`   
`ø
`
`
`
`BENET
` 
`
`
`
`
` 
`
` 
`
`

`

`UCSF School of Pharmacy Curriculum Vitae
` §
`
`
`
`£ ££
`Õ 
`
`I999.*
`Member, Editorial Board, The AAPS Journal
`¢¤œ
`­  
`›­3. 004ýþ  
`
` –———äç
`
`Member, Editorial Board, Chemistry and Pharmaceutical Bulletin
`2000-*
`¢¤œ
`­  
`›­œ
`/
  
` 

`  

`
`¡   äç
`
`
`
`Member, Editorial Board, Molecular Interventions
`2000-2009
`
` ¡   ä¡  —
` ¢¤œ
`­  
`›­œ
`5þ
`  1 
þ
`
`
`
`
`Member, Editorial Board, Drug Metabolism and Pharmacokinetics
`2002-2007
`
` ¡  ¡ä¡  ©
` ¢¤œ
`­  
`›­œ
`6 5  7þ
  
 

`
`
`
`
`Member, Editorial Board, Expert Opinion on Drug Metabolism and Toxicology
`2004-*
`¢¤œ
`­  
`›­œ
`89 :

þþ6 5  7þ
  .þ9

`þþ
`
` ¡  ìäç
`
`Member, Editorial Board. Current Drug Metabolism
`2004-2010
`¡  ìä¡ – 
` ¢¤œ
`­  
`›­š
`/ 6 5  7þ

`
`
`
`Member, Editorial Board, Archives of Drug Information
`2007-*
`¢¤œ
`­  
`›­œ
`0
`
1 þ6 þ 
þ
`
`
`
` ¡  ©äç
`
`
` 
`
`
`
`
`
`
`
`         ;
`
`Memberships in Scientific, Professional and Scholarly Societies
`‚ã܂ƒŒ‘’Œ
`‘€
`Ùڑ‚€‡‘à‘Úˆ
`Šƒ‹à‚ŒŒ‘‹€…Ž
`…€
`Ùڐ‹Ž…ƒŽ”
`ًڑ‚‡‘‚Œ
`
`
`
`Academy of Pharmaceutical Research and Science (elected Fellow, 1973)
`
` ™­
`
`£ 
`÷
`
­
` 

`ï­
`§¬œ
`–—©îò
`
`
`
`American Association for the Advancement of Science (elected Fellow, 1978)
`
` ™ 

`™  

`
`
`™­


`
` 

`ï­
`§¬œ
`–—©¨ò
`
`
`
`American Association of Colleges of Pharmacy
`
` ™ 

`™  

`
`ž
`
`
`
`
`
`
`American Association of Pharmaceutical Scientists (elected Fellow, 1986)
`
` ™ 

`™  

`
`£ 
` 
 
`ï­
`§¬œ
`–—¨Ÿò
`
`
`
`American Association of University Professors
`
` ™ 

`™  

`
`
 
`
`
`
`
`American College of Clinical Pharmacology (elected Fellow, 2009)
`
` ™ 

`ž
`
`

`ž
`ï­
`§¬œ
`¡  —ò
`
`
`
`American College of Clinical Pharmacy
`
` ™ 

`ž
`
`

`
`
`
`
`American Pharmacists Association
`
` ™ 

` 
`™  

`
`
`
`American Society for Clinical Pharmacology and Therapeutics
`
` ™ 

` 
`
`

`ž
`
­
`¯«£ 
`
`
`
`American Society for Pharmacology and Experimental Therapeutics
`
` ™ 

` 
`
`ž
`
­
`ß« 

`¯«£ 
`
`
`
`Controlled Release Society (elected Fellow, 2010)
`
` 
­
`÷
` 
`ï­
`§¬œ
`¡ – ò
`
`
`
`International Pharmaceutical Federation (FIP) (elected Honorary Member, 2012)
`
` ¥

 

`£ 
`§­ 

`痢ò
`ï­
`Þ

`¢¤œ
`¡ –¡ò
`
`
`
`International Society for the Study of Xenobiotics
`
` ¥

 

` 
`
`
`£­
`
`ú
¤  
`
`
`
`
`Japanese Society for the Study of Xenobiotics (elected International Honorary Member, 2007)
`ð«

` 
`
`
`£­
`
`ú
¤  
`ï­

 

`Þ

`¢¤œ
`¡  ©ò
`
`
`
`
`
`Phi Lambda Sigma
`
` 
`®¤­
` ž
`
`
`
`Rho Chi
`
` ÷
`
`
`
`
`2/1/2018
`   
`
`
`
`6
`2
`
`BENET
` 
`
`

`

`
`
`
`UCSF School of Pharmacy Curriculum Vitae
` §
`
`
`
`£ ££
`Õ 
`
`Sigma Xi
`
`  ž

`
`
`
`
`yi/2018
`   
`
`
`
`7
`<
`
`BENET
` 
`
`

`

`
`
`
`
`
`1982
`
` –—¨¡
`
`
`
`
`
`
`
`
`
`1985
`
` –—¨˜
`
`
`UCSF School of Pharmacy Curriculum Vitae
` §
`
`
`
`£ ££
`Õ 
`
`Honors and Awards
`“‹€‹ƒŒ
`…€
`|…ƒŒ
`
`
`
`Distinguished Teaching Award, Academic Senate, University of California, San Francisco.
`1972-73
`¦ 
ž£ ­
`¯
ž
`™¬­œ
`™­ 
`
œ
`
 
`
` 

`

`§
 š
`
`
` –—©¡ä©î
`
`
`
`Elected Fellow, Academy of Pharmaceutical Sciences.
`1973
`­
`§¬œ
`™­
`
`£ 
` 
š
`
`
` –—©î
`
`
`
`Keynote Speaker, Australian Pharmaceutical Sciences Association Meeting,
`1974
`ó

`«Öœ
`™£ 

`£ 
` 

`™  

`¢
žœ
`
`
`
` –—©ì
`
`Melbourne, Australia (August 15-17).
`¢¤£

`™£ 
`ž£
`–˜ä–©òš
`
`
`
`
`
`
`Keynote Speaker, Fourth National Interpharm Association Meeting,
`1976
`ó

`«Öœ
`§£
`° 

«
`™  

`¢
žœ
`
`
`
` –—©Ÿ
`
`Brighton, England (May 5-7).
`› ž
œ
ž
­
`ï¢
`˜ä©òš
`
`
`
`
`
`
`Keynote Speaker, Paris Interpharm Association, Paris, France (May 10).
`ó

`«Öœ
` 
«
`™  
œ
` œ
`§

`ï¢
`– òš
`
`
`
`
`
`
`Recipient, 600-year Anniversary Medal, Nicolas Copernicus
`÷ « 

`Ÿ  ä

`¢­œ
`° 
`«
£
`
`
`
`
`
`Medical Academy of Krakow, Poland (May 24).
`¢­ 
`™­
`
`óÖ¬œ
`
­
`ï¢
`¡ìòš
`
`
`
`
`
`
`Elected Fellow, American Association for the Advancement of Science.
`1978
`­
`§¬œ
`™ 

`™  

`
`
`™­


`
` 
š
`
`
` –—©¨
`
`
`
`Chairman, Pharmacology Study Section, National Institutes of Health. Member 1977-81.
`1979-81
` 
œ
`ž
`£­
` 
œ
`° 

 £
`
`Þš
`
`¢¤
`–—©©ä¨–š
`
`
` –—©—䨖
`
`
`
`First Annual A.I. White Lecturer, College of Pharmacy, Washington State University
`1981
`§ 
£
`™š¥š
`å 
`®£œ
`ž
`
`œ
`å
ž

`
`
 
`
`
` –—¨–
`
`(April 27-29).
` 
`¡©ä¡—òš
`
`Distinguished Alumnus of the Year, The University of Michigan College of Pharmacy.
`¦ 
ž£ ­
`™£
£
`
`
`ל
`¯
`
 
`
`¢  ž

`ž
`
`š
`
`Research Achievement Award in Pharmaceutics, American Pharmaceutical Association
`÷
`™ 

`™¬­
`

`£ œ
`™ 

`£ 
`™  

`
`Foundation/ Academy of Pharmaceutical Sciences.
`§£
­ 
ݙ­
`
`£ 
` 
š
`
`Pfizer Lecturer in Clinical Pharmacology, Louisiana State University Medical Center
` ë
`®£
`

`

`žœ
`®£  

`
`
 
`¢­ 
`

`
`(November 18-20).
`ï°¤
`–¨ä¡ òš
`
`Chairman, Pharmacological Sciences Review Committee, National Institute of General
` 
œ
`ž 
` 

`÷ ¬
` œ
`° 

 £
`
`Ø

`
`Medical Sciences. Member 1984-88.
`¢­ 
` 
š
`
`¢¤
`–—¨ì䨨š
`
`First Annual Edward R. Garrett Lecturer in Pharmaceutical Sciences,
`§ 
£
`­¬­
`÷š
`Ø
`®£
`

`£ 
` 
œ
`
`
`University of Florida (April 3).
`
`
 
`
`§ ­
` 
`îòš
`
`Doctor of Pharmacy, honoris causa. University of Uppsala, Sweden.
`¦
`
`œ
`
 
`£œ
`
 
`
` ««œ
`¬­
š
`
`Jubilee Lecturer, 150th Anniversary of the Founding of the Faculty of Pharmacy,
`𣤠
`®£œ
`–˜ 

`
`
`§£
­
ž
`
`
`§£
`
`œ
`
`University of Uppsala, Sweden (May 25).
`
`
 
`
` ««œ
`¬­

`ï¢
`¡˜òš
`
`Graduation Speaker, University of California School of Pharmacy (June 24).
`Ø­£ 

`«Öœ
`
 
`
` 

`
`
`
`ïð£

`¡ìòš
`
`Elected Fellow, American Association of Pharmaceutical Scientists.
`­
`§¬œ
`™ 

`™  

`
`£ 
` 
 š
`
`Election to the Institute of Medicine of the National Academy of Sciences.
` 

`
`
 £
`
`¢­ 

`
`
`° 

`™­
`
` 
š
`
`Smith Kline & French Distinguished Lectureship (Jan. 19).
` 
`ó


`§

`¦ 
ž£ ­
`®£ «
`ïð
š
`–—òš
`
`Member, Forum on Drug Development and Regulation, Institute of Medicine.
`¢¤œ
`§£
`

`¦£ž
`¦«

`
­
`÷ž£ 
œ
 £
`
`¢­ 

`
`(through 1994)
`
`–——ìò
`
`Varro E. Tyler Distinguished Lectureship, Purdue University (October 17,18)
`Õ
`š
`¯
`¦ 
ž£ ­
`®£ «œ
`£­£
`
 
`ïâ¤
`–©œ
`–¨ò
`
`Distinguished Service Award, American College of Clinical Pharmacology (October 31)
`8
`BENET
`¦ 
ž£ ­
` 
`™¬­œ
`™ 

`ž
`
`

`ž
`ïâ¤
`î–ò
`
`
` 
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1988
`
` –—¨¨
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`yi/2018
`
`
`
`   
`
`
`
`
`
`1986-88
`
` –—¨Ÿä¨¨
`
`
`
`
`1987
`
` –—¨©
`
`
`
`
`
`
`
`
`
`
`
`1987
`
` –—¨©
`
`
`

`

`UCSF School of Pharmacy Curriculum Vitae
` §
`
`
`
`£ ££
`Õ 
`
`
`
`
`
`
`
`1989
`
` –—¨—
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1990
`
` –—— 
`
`
`
`
`
`
`
`
`
`
`
`
` 
`
`
` 
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1991
`
` –——–
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1992
`
` –——¡
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`yi/2018
`
`
`   
`
`
`
`Parke-Davis Distinguished Scientist, University of Cincinnati (February 9,10)
`Öä¦ 
`¦ 
ž£ ­
` 
 œ
`
 
`
`


`理£
`—œ
`– ò
`
`Special Lecture, 109th Annual Meeting of the Pharmaceutical Society of Japan, Nagoya
`« 
`®£œ
`– —
£
`¢
ž
`
`
`£ 
` 
`
`ð«
œ
`°ž
`
`(April 4-6)
` 
`ìäŸò
`
`First American Association of Pharmaceutical Scientists Distinguished Scientist Award
`§ 
`™ 

`™  

`
`£ 
` 
 
`¦ 
ž£ ­
` 
 
`™¬­
`
`(October 25)
`ïâ¤
`¡˜ò
`
`Rho Chi Lecture Award (March 11)
`÷
`
`®£
`™¬­
`ï¢
`––ò
`
`Member, Generic Pharmaceutical Industry Association "Blue Ribbon" Committee on
`¢¤œ
`Ø
 
`£ 
­£
`™  

`>ݣ
`÷ ¤¤
>
` 
`

`
`Generic Medicines to Examine the Generic Drug Industry and the Drug Approval
`Ø
 
`¢­ 

`
`ß

`
`Ø
 
`¦£ž
­£
`
­
`
`¦£ž
`™««
`
`Process
`
`
`
`Member, Scientific Advisory Board, SmithKline Beecham Pharmaceuticals
`¢¤œ
` 
  
`™­ 
`›­œ
` ó

`›
`£ 
`
`(through 1994)
`
`–——ìò
`
`Long Teaching Award, School of Pharmacy, University of California, San Francisco, CA
`®
ž
`¯
ž
`™¬­œ
`
`
`œ
`
 
`
` 

`

`§
 œ
`™
`
`Elected Member, Bioavailability, Bioequivalence and Dissolution Subcommittee,
`­
`¢¤œ
`›  ¤  œ
`› ù£ 

`
­
`¦ £ 

`£¤ œ
`
`Committee on Revisions, The United States Pharmacopeial Convention, Inc. (through
` 
`

`÷  

`¯
`
­
`
`« 
`

 
œ

`
`
`1995)
`–——˜ò
`
`Member, Food and Drug Administration Generic Drugs Advisory Committee
`¢¤œ
`§­
`
­
`¦£ž
`™­
 

`Ø
 
`¦£ž
`™­ 
` 
`
`(through 1993)
`
`–——îò
`
`Volwiler Distinguished Research Achievement Award, American Association of
`Õ¬ 
`¦ 
ž£ ­
`÷
`™ 

`™¬­œ
`™ 

`™  

`
`
`Colleges of Pharmacy.
`ž
`
`š
`
`Distinguished Lecturer, Center for Bio-Pharmaceutical Sciences, Leiden University, The
`¦ 
ž£ ­
`®£œ
`

`
`› ä£ 
` 
œ
`® ­

`
 œ
`¯
`
`Netherlands (April 30 - May 3)
`°
­
` 
`î 

`¢
`îò
`
`Distinguished Lecturer, College of Pharmacy, University of Kentucky (October 9 -11)
`¦ 
ž£ ­
`®£œ
`ž
`
`œ
`
 
`
`ó
£Ö
`ïâ¤


`––ò
`
`Bristol-Myers Squibb Distinguished Lecturer, School of Pharmacy, State University of
`› ä¢
`ù£ ¤¤
`¦ 
ž£ ­
`®£œ
`
`
`œ
`
`
 
`
`
`New York, Buffalo (March 26-27)
`°¬
`×֜
`ݣ
`ï¢
`¡Ÿä¡©ò
`
`Plenary Speaker, First Annual Conference, United Kingdom Association of
`
`

`«Öœ
`§ 
£
`

œ
`
­
ž­
`™  

`
`
`Pharmaceutical Scientists, York, England (April 14-16)
`£ 
` 
 œ
`×֜
ž
­
` 
`–ì䖟ò
`
`President, 2nd Jerusalem Conference on Pharmaceutical Sciences and Clinical
`
` ­

­
`ð£
`


`

`£ 
` 

`
­
`

`
`Pharmacology, Jerusalem, Israel (May 24-29)
`žœ
`ð£œ
`¥
`ï¢
`¡ì䡗ò
`
`Co-Chair, "Workshop: Women and Drug Development," Institute of Medicine,
`ä œ
`>åÖ«ô
`å

`
­
`¦£ž
`¦«
œ>
 £
`
`¢­ 

`
`Washington, D.C., (June 22,23)
`å
ž
œ
`¦ššœ
`ïð£

`¡¡œ¡îò
`
`Visiting Professor, Dalhousie University, College of Pharmacy & Department of
`Õ  
ž
`œ
`¦£ 
`
 œ
`ž
`
`

`¦«

`
`
`Pharmacology, College of Medicine, Halifax, Nova Scotia (October 22,23)
`žœ
`ž
`
`¢­ 

`Þ ߜ
`°
` 
`ïâ¤
`¡¡œ
`¡îò
`
`
`Krantz Lectureship, Philadelphia College of Pharmacy and Science, Philadelphia
`ó

`®£ «œ
` ­« 
`ž
`
`
`
­
` 
œ
` ­« 
`
`(December 10)
`捻
`– ò
`
`
`9
`=
`
`BENET
` 
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UCSF School of Pharmacy Curriculum Vitae
` §
`
`
`
`£ ££
`Õ 
`
`American Foundation for Pharmaceutical Education Distinguished Service Profile
`1993
`™ 

`§£
­ 

`
`£ 
`­£ 

`¦ 
ž£ ­
` 
` 
`
`
` –——î
`
`Award (January 12)
`™¬­
`ïð
£
`–¡ò
`
`Member, Science Board, Food and Drug Administration (through 1998)
`¢¤œ
` 

`›­œ
`§­
`
­
`¦£ž
`™­
 

`
`–——¨ò
`
`Chair, Committee on Antiprogestins: Assessing the Science, Institute of Medicine
` œ
` 
`

 «ž

`™
ž
`
` 
œ
 £
`
`¢­ 

`
`Co-Chair, "Enzymes of Drug Metabolism: Importance to Drug Safety and Efficacy,"
`ä œ
`>
ë
`
`¦£ž
`¢¤ ô
`¥«

`
`¦£ž
`
`
­
` œ>
`
`Institute of Medicine, Washington, DC (January 25,26)
 £
`
`¢­ 

`å
ž
œ
`¦
`ïð
£
`¡˜œ
`¡Ÿò
`
`Distinguished Lecturer, College of Pharmacy, University of Utah (February 16-18)
`¦ 
ž£ ­
`®£œ
`ž
`
`œ
`
 
`
` 
`理£
`–Ÿä–¨ò
`
`Merck Series Lecturer, The Raabe College of Pharmacy, Ohio Northern University
`¢Ö
` 
`®£œ
`¯
`÷¤
`ž
`
`œ
`â 
`°

`
 
`
`(March 30)
`ï¢
`î ò
`
`Chair, "Workshop on Antiprogestins: Assessing the Science," Institute of Medicine,
` œ
`>åÖ«
`

 «ž

`™
ž
`
` 
œ>
 £
`
`¢­ 

`
`Washington, DC (April 13,14)
`å
ž
œ
`¦
` 
`–îœ
`–ìò
`
`Member, Membership Committee, Institute of Medicine (through 1997)
`¢¤œ
`¢¤ «
` œ
 £
`
`¢­ 

`
`–——©ò
`
`John G. Wagner Lectureship Award in Pharmaceutics, College of Pharmacy, University
`ð

`ؚ
`åž

`®£ «
`™¬­
`

`£ œ
`ž
`
`œ
`
 
`
`of Michigan, Ann Arbor, MI (September 29)
`
`¢  ž
œ

`™¤œ
`¢¥
`﫤
`¡—ò
`
`Rawls Palmer Progress in Medicine Award, American Society for Clinical
`÷¬
`
`ž
`

`¢­ 

`™¬­œ
`™ 

` 
`
`

`
`Pharmacology and Therapeutics (March 15)
`ž
`
­
`¯«£ 
`ï¢
`–˜ò
`
`Doctor of Philosophy, honoris causa, Leiden University, The Netherlands (June 9)
`¦
`
` «œ
`
 
`£œ
`® ­

`
 œ
`¯
`°
­
`ïð£

`—ò
`
`Therapeutic Frontiers Lecturer, American College of Clinical Pharmacy (August 7)
`¯«£ 
`§
 
`®£œ
`™ 

`ž
`
`

`
`ž£
`©ò
`
`Keynote Speaker, FIP Bio-International '96, Tokyo, Japan (April 22-23)
`ó

`«Öœ
`§¥
`› ä¥

 

`?—Ÿœ
`¯Öœ
`ð«

` 
`¡¡ä¡îò
`
`Keynote Speaker, 23rd International Symposium on Controlled Release of Bioactive
`ó

`«Öœ
`¡î­

 

`« £
`

`
­
`÷
`
`›  
`
`Materials, Kyoto, Japan (July 8-10)
`¢ œ
`óœ
`ð«

`ïð£
`¨ä– ò
`
`Medeval Distinguished Lecturer in Pharmaceutical Sciences, The University of
`¢­
`¦ 
ž£ ­
`®£
`

`£ 
` 
œ
`¯
`
 
`
`
`Manchester, Manchester, England (October 8)
`¢
œ
`¢
œ
ž
­
`ïâ¤
`¨ò
`
`Distinguished Service Award, American Association of Pharmaceutical Scientists,
`¦ 
ž£ ­
` 
`™¬­œ
`™ 

`™  

`
`£ 
` 
 œ
`
`(October 27)
`ïâ¤
`¡©ò
`
`The
`Keynote Speaker, Annual First Tennessee Endowed Chair Symposium,
`ó

`«Öœ
£
`§ 
`¯

­¬­
` 
`« £œ
`
`
`
`
`
`
`
`¯
`
`University of Tennessee, Memphis (November 4)
`
`
 
`
`¯
œ
`¢« 
`ï°¤
`ìò
`
`Graduation Speaker, College of Pharmacy, University of Illinois at Chicago, Chicago,
`Ø­£ 

`«Öœ
`ž
`
`œ
`
 
`
`¥
 
`
` žœ
` žœ
`
`Illinois (May 8)
`¥
 
`ï¢
`¨ò
`
`Doctor of Science, honoris causa. University of Illinois, Chicago (May 11)
`¦
`
` 
œ
`
 
`£œ
`
 
`
`¥
 œ
` ž
`ï¢
`––ò
`
`Doctor of Science, honoris causa, Philadelphia College of Pharmacy and Science,
`¦
`
` 
œ
`
 
`£œ
` ­« 
`ž
`
`
`
­
` 
œ
`
`Philadelphia (May 12)
` ­« 
`ï¢
`–¡ò
`
`Nominated by HHS Secretary Donna E. Shalala as 1 of 8 candidates forwarded to
`°
­
`¤
`ÞÞ
`
`¦

`š
`
`

`

`
­ ­
`¬­­
`
`
`President Clinton for the post of FDA Commissioner
`
` ­

`


`
`
`«
`
`§¦™
`  

`
`
`
`
`1995
`
` –——˜
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1996
`
` –——Ÿ
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1997
`
` –——©
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`yi/2018
`
`
`
`   
`
`
`
`10
` 
`
`BENET
` 
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1999
`
` –———
`
`
`
`
`UCSF School of Pharmacy Curriculum Vitae
` §
`
`
`
`£ ££
`Õ 
`
`Chair, External Peer Review Committee FDA Center for Biologies Evaluation and
`1998
` œ
`ß

`
`÷ ¬
` 
`§¦™
`

`
`› ž 
`£ 

`
­
`
`
` –——¨
`
`Research
`÷
`
`Chair, FDA Expert Panel on Individual Bioequivalence (through 1999)
` œ
`§¦™
`ß«
`

`

­  ­£
`› ù£ 

`
`–———ò
`
`Plenary Lecturer, 13th Annual Meeting of the Academy of Pharmaceutical Science and
`
`

`®£œ
`–î
£
`¢
ž
`
`
`™­
`
`£ 
` 

`
­
`
`Technology Japan, Kofu, Japan (March 26)
`¯
ž
`ð«
œ
`ó£œ
`ð«

`ï¢
`¡Ÿò
`
`Plenary Lecturer, 118th Meeting of the Pharmaceutical Society of Japan, Kyoto, Japan
`
`

`®£œ
`––¨
`¢
ž
`
`
`£ 
` 
`
`ð«
œ
`óœ
`ð«

`
`(April 1)
` 
`–ò
`
`Nagai Foundation Distinguished Lecturer, Tokyo, Japan (June 10)
`°ž
`§£
­ 

`¦ 
ž£ ­
`®£œ
`¯Öœ
`ð«

`ïð£

`– ò
`
`Graduation Speaker, School of Pharmacy, University of California, San Francisco (June
`20)
`Ø­£ 

`«Öœ
`
`
`œ
`
 
`
` 

`

`§
 
`ïð£

`
`¡ ò
`
`Doctor of Science, honoris causa. Long Island University, Brooklyn, NY (May 21)
`¦
`
` 
œ
`
 
`£œ
`®
ž
`¥
­
`
 œ
`›Ö
œ
`°×
`ï¢
`¡–ò
`
`Graduation Speaker, 110th Commencement, Arnold & Marie Schwartz College of Pharmacy and
`Ø­£ 

`«Öœ
`–– 
`


`™
­

`¢ 
`‘
`ž
`
`
`
­
`
`Health Sciences, Long Island University, Brooklyn, NY (May 21)
`Þ
` 
œ
`®
ž
`¥
­
`
 œ
`›Ö
œ
`°×
`ï¢
`¡–ò
`
`Member, Scientific Advisory Board, Roche Biosciences (through 2001)
`¢¤œ
` 
  
`™­ 
`›­œ
`÷
`›  

`
`¡  –ò
`
`
`
`Keynote Lecturer, 31st Annual Pharmaceutics Graduate Students Research Meeting Kansas City
`
` ó

`®£œ
`î–
£
`£ 
`Ø­£
`£­

`÷
`¢
ž
`ó

` 
`
`(June 25)
`ïð£

`¡˜ò
`
`Keynote Lecturer, 1999 Medeval Symposium, Manchester, England (September 28)
`ó


This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket